Lung Cancer Organoid Model Registry
Patient-derived organoids that faithfully recapitulate keratinizing squamous cell carcinoma histology — including spontaneous keratin pearl formation — fill a critical gap in LUSC preclinical modeling, but these rare models are scattered across individual labs with no shared registry.
Lung Cancer Organoid Model Registry
Patient-derived organoids that faithfully recapitulate keratinizing squamous cell carcinoma histology — including spontaneous keratin pearl formation — fill a critical gap in LUSC preclinical modeling, but these rare models are scattered across individual labs with no shared registry.
Build a searchable registry of patient-derived lung cancer organoid models, cataloging available organoid lines by histological subtype (LUSC keratinizing, LUSC non-keratinizing, LUAD, SCLC, etc.), key biomarkers expressed, genomic features, drug sensitivity data available, and contact information for the originating lab. Each model entry would include verification metadata: histological images showing fidelity to parent tumor, marker expression panels, and any published drug response data.
The registry would include a model request facilitation system — researchers who need a specific LUSC organoid model for drug screening could search the registry and submit a collaboration request. A forum layer would allow organoid labs to discuss protocol optimizations, culture conditions for specific subtypes, and challenges in maintaining fidelity to primary tumor morphology.
Lung squamous cell carcinoma remains one of the hardest-to-treat lung cancers partly because preclinical models don't recapitulate its biology. With patient-derived organoids that now faithfully reproduce keratinizing morphology, the bottleneck shifts to awareness and access. A registry that connects drug developers and researchers with appropriate models could significantly reduce the time from promising drug candidates to meaningful preclinical testing in relevant LUSC models.
Who Is This For?
Lung cancer researchers who need validated preclinical models, pharmaceutical companies running drug screens, and organoid labs seeking collaboration and model sharing opportunities.
Skills & Tools Needed
- Web development (database and search interface)
- Knowledge of lung cancer histological subtypes and organoid biology
- Scientific curation and metadata standardization
- Community management and researcher outreach
- Integration with existing model registries (ATCC, DSMZ conventions)
Feasibility
high — A model registry is a well-understood format (similar to cell line registries) — the main effort is initial curation, outreach to lung cancer organoid labs, and building a clean search interface.
